| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.7M | — | +137.7% |
| Cost of Revenue | $1.3M | — | +21.6% |
| R&D Expense | $81.1M | — | +11.6% |
| SG&A Expense | $48.3M | — | +16.3% |
| Operating Income | -$110.0M | — | -3.2% |
| Net Income | -$99.1M | — | -11.0% |
| EPS (Basic) | -$1.69 | — | -9.0% |
| EPS (Diluted) | -$1.69 | — | -9.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $113.6M | +27.5% | +43.9% |
| Inventory | $35.1M | +6.6% | +18.5% |
| Current Assets | $834.8M | -11.4% | -13.8% |
| Total Assets | $1.18B | -8.7% | -23.8% |
| Current Liabilities | $58.8M | -28.4% | +12.4% |
| Total Liabilities | $75.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$118.9M | — | -6.7% |
| Capital Expenditures | $769K | — | +0.4% |
| Investing Cash Flow | $141.3M | — | +25.5% |
| Financing Cash Flow | $2.1M | — | +28.4% |
| Free Cash Flow | -$119.7M | — | -6.6% |
| -14.7% |
| Stockholders' Equity | $1.11B | -7.0% | -24.4% |